update

Fabbrica Italiana Sintetici Expands IMCD Promotion Deal

Related tags European union Europe

IMCD gets new API deal
IMCD gets new API deal
IMCD Group will promote APIs made by Italian firm FIS in territories in Eastern Europe and the Southern hemisphere under a new agreement. 

The deal -terms of which were not disclosed - will see IMCD market Fabbrica Italiana Sintetici's (FIS) active pharmaceutical ingredients (API) to drugmakers in Hungary, Slovenia, Serbia, Croatia, Macedonia, Bosnia and Herzegovina, Albania, Australia and New Zealand.

An IMCD spokeswoman told in-Pharmatechnologist.com that: "We are promoting FIS products, existing ones and pipeline of new developments, visiting customers, following new developments and projects with customers.

"We are forwarding purchase orders to FIS but FIS is selling, transporting and invoicing customers. FIS is providing us with all shipping documents for customers​."

She added that IMCD has worked with FIS' API business since 2009 when it because its agent in Central and Eastern Europe, most CIS countries and Russia and Austria.

Montecchio Maggiore, Italy-headquartered FIS makes anxiolytics, anticonvulsants, antidepressants, analgesics, anti- inflammatory agents, antibacterials, antifungals, cardiovascular drugs, diuretics, oncological products and hormones. 

NZ and Australia

The new agreement follows just a few weeks after IMCD increased its presence in the Australia through the acquisition of Bella Vista, New South Wales-based drug and food ingredient distributor Capitol Ingredients.

However, while IMCD told us that it is keen to use its acquisition to expand its presence in Australia's pharma and nutraceutical market - the agreement with FIS will not involve Capitol Ingredients.

IMCD has been building its pharmaceutical business since 2011 when it bought South African chemicals and formulation supplier Ethnichem in 2011.

That pharma related-deal was followed by the acquisition of Italian fine chemicals supplier Organotec , Malaysian ingredient and excipient distributor Maxwell Pharma and – in February this year – India’s Indchem​.

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us

Products

View more

Webinars